Belite Bio (BLTE) Return on Assets (2023 - 2026)

Belite Bio (BLTE) has reported Return on Assets for 4 consecutive years, with 0.8% the latest figure, recorded in Q1 2026.

• In Q1 2026, Return on Assets rose 99.0% year-over-year to 0.8%; the TTM figure through Mar 2026 stood at 0.8% (up 99.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
• Return on Assets came in at 0.8% for Q1 2026 at Belite Bio, up from 1.19% in the prior quarter.
• The five-year high for Return on Assets was 0.8% in Q1 2026, with the low at 3.21% in Q2 2023.
• Average Return on Assets over 4 years is 2.02%, with a median of 2.19% recorded in 2025.
• The largest YoY upside for Return on Assets was 162 bps in 2024 against a maximum downside of 89 bps in 2024.
• Year by year, Return on Assets stood at 1.8% in 2023, then plunged by 50 bps to 2.7% in 2024, then jumped by 56 bps to 1.19% in 2025, then jumped by 33 bps to 0.8% in 2026.
• According to Business Quant data, Return on Assets over the past three periods registered 0.8%, 1.19%, and 2.19% for Q1 2026, Q4 2025, and Q3 2025 respectively.